HRTX — Heron Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $160.82m
- $255.88m
- $154.90m
Annual cashflow statement for Heron Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -221 | -182 | -111 | -13.6 | -20.2 |
| Depreciation | |||||
| Non-Cash Items | 49.4 | 42.7 | 32.1 | 16.2 | 22.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -35.1 | -10.5 | 16.8 | -27.6 | -31.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -203 | -147 | -58.8 | -22.5 | -27.6 |
| Capital Expenditures | -3.02 | -1.82 | -1.54 | -1.71 | -0.317 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 35.8 | -1.5 | 19.5 | 20.4 | 16.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 32.7 | -3.32 | 18 | 18.7 | 16 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 156 | 75.1 | 54.1 | 0.94 | 14.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -14.6 | -75.2 | 13.3 | -2.88 | 2.85 |